Published in J Mol Cell Cardiol on July 14, 2007
Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull (2011) 2.26
Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev (2013) 2.24
Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol (2010) 1.75
Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. J Mol Cell Cardiol (2012) 1.45
Utility of dual-modality bioluminescence and MRI in monitoring stem cell survival and impact on post myocardial infarct remodeling. Acad Radiol (2011) 1.45
Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol (2010) 1.33
Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay. Am J Physiol Heart Circ Physiol (2008) 1.28
Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. Heart Rhythm (2008) 1.19
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc Natl Acad Sci U S A (2009) 1.10
Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ Res (2014) 1.09
Cardiac differentiation of pluripotent stem cells. Stem Cells Int (2011) 1.09
Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol (2012) 1.00
Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cell Mol Life Sci (2009) 1.00
Cardiac applications for human pluripotent stem cells. Curr Pharm Des (2009) 0.97
Injection of isolated mitochondria during early reperfusion for cardioprotection. Am J Physiol Heart Circ Physiol (2008) 0.94
Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes. Circ Cardiovasc Imaging (2010) 0.92
Concise review: cell therapy and tissue engineering for cardiovascular disease. Stem Cells Transl Med (2012) 0.90
Engineered human cardiac tissue. Pediatr Cardiol (2011) 0.89
Current stem cell delivery methods for myocardial repair. Biomed Res Int (2012) 0.89
Cell-based delivery of dATP via gap junctions enhances cardiac contractility. J Mol Cell Cardiol (2014) 0.84
Generation of human female reproductive tract epithelium from human embryonic stem cells. PLoS One (2011) 0.83
Embryonic Stem Cells as a Model for Cardiac Development and Disease. Drug Discov Today Dis Models (2008) 0.83
Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed Res Int (2014) 0.83
Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends. Indian J Med Res (2013) 0.82
Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.82
Fast and efficient multitransgenic modification of human pluripotent stem cells. Hum Gene Ther Methods (2014) 0.82
Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo. Stem Cells Transl Med (2014) 0.82
Marching towards regenerative cardiac therapy with human pluripotent stem cells. Discov Med (2013) 0.80
Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering. Biomark Insights (2015) 0.80
Uses of cardiomyocytes generated from induced pluripotent stem cells. Stem Cell Res Ther (2011) 0.78
Update: cardiac xenotransplantation. Curr Opin Organ Transplant (2008) 0.75
Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes against Ischemia/Reperfusion Injury. Oxid Med Cell Longev (2016) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation (2003) 6.30
Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell (2006) 6.19
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J (2006) 5.93
Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res (2003) 5.12
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol (2003) 4.91
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol (2004) 4.50
Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J (2007) 4.32
Pluripotency of spermatogonial stem cells from adult mouse testis. Nature (2006) 4.29
Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation (2005) 4.03
Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest (1996) 3.87
Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res (2002) 3.69
Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science (1994) 3.24
Cardiac regeneration: repopulating the heart. Annu Rev Physiol (2006) 2.92
Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res (2004) 2.92
Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res (2003) 2.86
Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol (2005) 2.60
Cardiac cell therapy--mixed results from mixed cells. N Engl J Med (2006) 2.52
Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet (2005) 2.36
Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol (2003) 2.35
Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (2005) 2.24
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells (2005) 2.23
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21
Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation (2005) 2.12
Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol (2003) 2.05
Two-photon microscopy of cells and tissue. Circ Res (2004) 1.95
Human embryonic stem cells possess immune-privileged properties. Stem Cells (2004) 1.82
Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol (2004) 1.71
Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality. EMBO J (2000) 1.70
Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res (2003) 1.66
Two-photon molecular excitation imaging of Ca2+ transients in Langendorff-perfused mouse hearts. Am J Physiol Cell Physiol (2003) 1.62
Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest (1993) 1.58
Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J (2000) 1.56
Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells (2006) 1.52
Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res (2005) 1.48
Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest (2004) 1.38
The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat Methods (2005) 1.35
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation (2005) 1.32
Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation (2002) 1.32
Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng (2005) 1.28
Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online (2006) 1.14
Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells (2006) 1.13
Visceral-endoderm-like cell lines induce differentiation of murine P19 embryonal carcinoma cells. Differentiation (1991) 1.06
Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol (2003) 1.00
Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies. Cytotherapy (2003) 0.96
Embryonic stem cells share immune-privileged features relevant for tolerance induction. J Mol Med (Berl) (2002) 0.92
Cardiac repair by embryonic stem-derived cells. Handb Exp Pharmacol (2006) 0.85
Allogeneic stem cells, clinical transplantation and the origins of regenerative medicine. Curr Opin Immunol (2002) 0.81
Stem cell therapy for the heart. Congest Heart Fail (2004) 0.78
Stem cell transplantation for the treatment of myocardial infarction. Transpl Immunol (2005) 0.78
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature (2008) 10.27
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation (2003) 6.30
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 5.20
Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol (2002) 4.82
Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation (2005) 4.03
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol (2002) 3.79
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell (2010) 3.41
Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res (2004) 3.30
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol (2005) 3.15
Cardiomyocyte cell cycle regulation. Circ Res (2002) 2.99
Stem cell states, fates, and the rules of attraction. Cell Stem Cell (2009) 2.96
Cardiac regeneration: repopulating the heart. Annu Rev Physiol (2006) 2.92
Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res (2004) 2.92
Karyotype of human ES cells during extended culture. Nat Biotechnol (2004) 2.81
Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell (2009) 2.78
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2012) 2.78
A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc (2007) 2.76
Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation (2010) 2.52
No-reflow phenomenon. Circulation (2002) 2.30
Cell-based cardiac repair: reflections at the 10-year point. Circulation (2005) 2.25
Differential cardiac remodeling in preload versus afterload. Circulation (2010) 2.20
Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res (2003) 2.14
Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells (2004) 2.05
Cardiovascular effects of cocaine. Circulation (2010) 2.05
Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J Am Coll Cardiol (2008) 2.02
Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res (2007) 1.90
Human corneal endothelial cell expansion for corneal endothelium transplantation: an overview. Transplantation (2011) 1.84
Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice. Circ Res (2004) 1.84
Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol (2005) 1.83
Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells (2004) 1.83
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. Stem Cells (2009) 1.79
The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell (2007) 1.75
Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod (2007) 1.75
Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium. Mol Ther (2008) 1.75
The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell (2008) 1.73
Comparison of automated oscillometric versus auscultatory blood pressure measurement. Am J Cardiol (2010) 1.66
Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation (2007) 1.66
Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res (2003) 1.66
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J (2012) 1.65
Two-photon molecular excitation imaging of Ca2+ transients in Langendorff-perfused mouse hearts. Am J Physiol Cell Physiol (2003) 1.62
Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway. Circulation (2008) 1.61
Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell (2011) 1.58
RNA-binding protein RBM24 is required for sarcomere assembly and heart contractility. Cardiovasc Res (2012) 1.57
Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation (2008) 1.56
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med (2006) 1.53
Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol (2006) 1.52
Formation of human prostate tissue from embryonic stem cells. Nat Methods (2006) 1.50
Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev (2011) 1.49
Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res (2005) 1.48
Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation. Cardiovasc Res (2003) 1.47
The "no-reflow" phenomenon: basic science and clinical correlates. Heart (2002) 1.46
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. J Am Coll Cardiol (2005) 1.46
Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol (2003) 1.46
The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension. J Clin Hypertens (Greenwich) (2003) 1.44
High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. J Invasive Cardiol (2011) 1.43
Neural modulation of cardiac arrhythmias and sudden cardiac death. Heart Rhythm (2006) 1.42
Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev (2007) 1.41
Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation (2011) 1.39
Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells. Stem Cells (2007) 1.38
Rotational atherectomy in the drug-eluting stent era: a single-center experience. J Invasive Cardiol (2011) 1.38
Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest (2004) 1.38
Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol (2008) 1.35
The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol (2006) 1.32
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation (2002) 1.32
Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc (2007) 1.31
Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J (2011) 1.29
Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol (2009) 1.29
Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng (2005) 1.28
A 4-year update on the safety of sildenafil citrate (Viagra). Urology (2002) 1.28
Lamin B1 fluctuations have differential effects on cellular proliferation and senescence. J Cell Biol (2013) 1.28
Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function. J Biol Chem (2008) 1.24
Heterogeneous upregulation of apamin-sensitive potassium currents in failing human ventricles. J Am Heart Assoc (2013) 1.24
Dishevelled-associated activator of morphogenesis 1 (Daam1) is required for heart morphogenesis. Development (2011) 1.24
Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv (2008) 1.24
Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat Commun (2013) 1.23
Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med (2003) 1.22
Lineage tracing of cardiac explant derived cells. PLoS One (2008) 1.22